Ziprasidone Capsules

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-25-D-0004

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Toronto, Ontario, CANADA

SourceSAM
Documents1
The Defense Logistics Agency (DLA) Troop Support has issued an award notice under procurement identifier SPE2D2-25-D-0004 for the supply of Ziprasidone Capsules. This procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code (PSC) 6505, indicating a focus on drugs and biologicals. The primary objective of this procurement is to secure a reliable supply of Ziprasidone Capsules, a pharmaceutical product used in the treatment of certain mental/mood disorders, for use by federal agencies or military healthcare facilities. The place of performance for this contract is specified as Toronto, Ontario, Canada, indicating that the manufacturing or distribution activities related to this award will be based in this location. DLA Troop Support, a federal office responsible for providing logistical and supply chain support to the U.S. military and other federal entities, serves as the contracting entity for this award. The agency’s role ensures that the procured pharmaceuticals meet stringent quality and regulatory standards, supporting the health and readiness of service members and other beneficiaries. Key requirements and deliverables for this contract include the consistent manufacturing and timely delivery of Ziprasidone Capsules in accordance with federal specifications and applicable regulatory guidelines. While the notice does not specify detailed quantities, packaging, or delivery schedules, contractors are expected to adhere to all relevant pharmaceutical manufacturing standards and ensure product integrity throughout the contract lifecycle. The notice is currently active and was posted on January 22, 2025. Interested parties or stakeholders seeking further information may contact the primary point of contact, Christopher Newman, at [email protected] or by phone at 215-737-2905. A secondary contact, Jason Wray, is also available at [email protected] or 215-737-0614. This award notice does not specify any set-aside requirements or special considerations such as small business preferences. Contractors evaluating this opportunity should note the international place of performance and ensure compliance with all applicable cross-border trade and regulatory requirements. For additional details or to review the official award documentation, interested parties can refer to the notice on SAM.gov using the Opportunity ID cd1d5e3fc71240ae9207bb3d8eaf1290 or visit the provided URL: https://sam.gov/opp/cd1d5e3fc71240ae9207bb3d8eaf1290/view. In summary, this procurement represents a strategic effort by DLA Troop Support to maintain a secure and compliant supply chain for essential pharmaceutical products, with a focus on quality, reliability, and regulatory adherence throughout the contract period.